You probably don’t need a scientific study to tell you that working for a narcissistic boss can have negative effects on your performance and mental health.
It is likely to be at least 10 years before any new generation of antidepressants comes to market, despite evidence that depression and anxiety rates are increasing across the world, specialists said on Wednesday.
The cost to raise a child in the United States is down from last year, but the experience still requires spending a pretty penny, a new report by the U.S. Department of Agriculture (USDA) suggests.
A 12-year-old boy in Massachusetts was hospitalized after ingesting a marijuana edible on his public school bus, and now local school officials are trying to figure out where he got the substance so other students aren’t harmed.
Ordering things on Amazon offers a convenience for many families, but the service provides the Bickneses of Tuscon, much more— namely, a chance to stay home with 8-year-old Ben Bicknese, whose immune system is weakened due to cancer treatment.
Kolton Hessman was born with his heart on the wrong side of his chest, and ever since November, the 3-year-old has been on life support as he waits for a donor organ that doctors hope will make him new again.
Johnson & Johnson plans next month to disclose average price increases of its prescription drugs, as the industry tries to calm the storm over soaring prices.
Philippine President Rodrigo Duterte has ordered government agencies to ensure free access to contraceptives for 6 million women who cannot obtain them, officials said Wednesday, in a move expected to be opposed by the dominant Roman Catholic church.
Scampering up the wall of his tin shack in Bangladesh's capital, three-year-old Rozzob Ali has the same combination of mischief, charm and boisterous energy as many other boys.
China will add 89,000 new hospital beds and train 140,000 new obstetricians and nurses in order to deal with the strains on its healthcare system brought about in part by the relaxation of its "one-child policy", state media said on Wednesday.
Merck & Co on Tuesday said the FDA agreed to a speedy review of its application to combine its immunotherapy drug Keytruda with chemotherapy as an initial treatment for advanced lung cancer, potentially giving it a major leg up in the competition for the largest cancer market.